GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM 2025) has revealed.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup